Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to ALNY Full portfolio

Position in ALNY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$93,333,446
-$20,076,545 QoQ
Shares Held
310,047
-9.5% QoQ
Ownership
0.232%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#55
of 780 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Derivatives in ALNY

reported options exposure · as of Jun 30, 2026
CallValue
$111,381,100
CallShares
370,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,774,320 across 417 Biotechnology names. ALNY ranks #3 (6.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
This page 		310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ALNY

Export CSV
35 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $111,381,100 370,000
2026-06-30 $93,333,446 310,047
2026-03-31 $113,409,991 342,763
2026-03-31 $122,421,900 370,000
2025-12-31 $147,130,500 370,000
2025-12-31 $102,450,544 257,640
2025-09-30 $127,939,008 280,568
2025-09-30 $9,120,000 20,000
2025-06-30 $104,943,586 321,824
2025-06-30 $6,521,800 20,000
2025-03-31 $81,027,599 300,080
2025-03-31 $5,400,400 20,000
2024-12-31 $4,706,200 20,000
2024-12-31 $65,171,926 276,962
2024-09-30 $73,294,668 266,497
2024-06-30 $50,093,964 206,148
2024-03-31 $30,841,098 206,364
2023-12-31 $43,953,477 229,630
2023-09-30 $47,061,668 265,735
2023-06-30 $49,200,157 259,030
2023-03-31 $48,971,428 244,466
2022-12-31 $47,391,210 199,416
2022-09-30 $12,772,607 63,812
2022-06-30 $10,619,044 72,808
2022-03-31 $10,501,015 64,309
2021-12-31 $7,659,418 45,167
2021-09-30 $25,725,359 136,250
2021-06-30 $24,888,924 146,820
2021-03-31 $21,956,454 155,510
2020-12-31 $16,000 5,300
2020-12-31 $28,408,320 218,576
2020-09-30 $36,342,486 249,605
2020-09-30 $21,000 5,300
2020-06-30 $35,834,621 241,946
2020-03-31 $27,140,005 249,334

Report a Problem

Category
Description
Email (optional, for follow-up)